Thus, the effect of TGF‐β in CRC can be diverse and context‐dependent, and the mechanisms, which disconnect the tumor‐promoting effects from its tumor‐suppressive effects, are still not fully understood. This evidence concerns the gene TGFB1 and colorectal carcinoma.